Chairman and Director
Don Wright brings decades of informatics and healthcare leadership to Inagene Diagnostics. Don is currently the President and CEO of Clarigent Health. Prior to Clarigent, he spent the past decade as Founder growing Assurex Health from technology invented at Mayo Clinic and Cincinnati Children’s Hospital Medical Center to a company of over 500 employees serving almost one million people with mental health conditions. After raising over $86MM in private equity, Assurex was acquired in 2016 by Myriad Genetics for $225MM - plus an additional $175MM in performance-based incentives. The large and successful exit was subsequently honored with Venture Ohio's Exit of the Year award.
Don has served as vice president of product development at Attachmate, leading a 450-person worldwide product development organization. Don has also served as CTO for Spotlight Solutions, a leading provider of retail pricing and revenue optimization products, as well as working on the merger with ProfitLogic, which was sold to Oracle. Don also served as vice president and CIO for Domin-8 Enterprise Solutions, overseeing web-based product offerings, which grew to over six million units under management. Before Assurex, Don was co-founder and CTO of SaaS Capital, a specialty finance company serving the SaaS software market. Don is now using his more than 25 years of experience to assist others turning their ideas into hyper-growth companies.
Co-Founder and Director
Alan is the founder of Minett Capital and co-founder and Chairman of GreenSoil Investments, with a portfolio of venture capital funds focused on investing in companies that enable smart and efficient utilization of resources in two distinct verticals — food/ag tech and real estate tech. He is also the co-founder of Your Music Memory, a world class, unique, iconic, rock 'n roll memorabilia collection focusing on the art of the album cover.
Alan spent almost 30 years in progressively senior positions within his family business, the Minto Group of Companies (www.minto.com), a real estate development business across Canada and in Florida. Until mid-2011, Alan was President and COO of MintoUrban Communities Inc., which focused on residential high-rise condominium development in urban Toronto and residential rentals in Canada. Alan recently retired from all his remaining responsibilities at Minto. In 2016, Alan co-founded City Club Apartments LLC. City Club Apartments is actively developing, owning and managing apartment rentals throughout the MidWest US. More recently, Alan founded Streamliner Properties, which is actively investing in value-add real estate properties in the Greater Toronto Area.
Alan holds a Bachelor of Commerce & Economics from the University of Toronto, sits on the Board of Directors of The Association for Soldiers of Israel as well as Save a Childs Heart. He is a Director Emeritus of the Siminovitch Prize, and sits on the following corporate boards: BridgeGreen Capital (Canada), BioHarvest Inc (Israel), Goby Inc (USA), Electric IQ (USA), Haldor Inc. (Israel) and Inagene Diagnostics (Canada).
Co-Founder, Director and Chief Science Advisor
Katherine Siminovitch, M.D., FRCP(C), FRSC, ABIM, a Professor at the University of Toronto and a Senior Investigator at Lunenfeld-Tanenbaum Research Institute and Senior Scientist, Toronto General Hospital Research Institute, founded and directs the MSH/UHN Clinical Genomics Centre (CGC). The CGC provides high throughput genotyping and sequencing services and has undertaken over 10,000 individual genetic analyses providing worldwide service for over 15 years. Dr. Siminovitch directs the Litwin Centre for Genetic Medicine, a provincial centre of excellence for provision of clinical genetics care, providing more than 1,000 reports of genetic results each year.
In 2005, Dr. Siminovitch was awarded the Canadian Society for Clinical Investigation/Royal College of Physicians and Surgeon of Canada Henry Friesen Research Award. Some of her previous honors include the University of Toronto Dales Award for Medical Research and Institute of Medical Sciences Mel Silverman Mentorship Award, the American College of Rheumatology Henry Kunkel Young Investigator Award and, in 1993, election to the American Society of Clinical Investigation. Dr. Siminovitch was awarded a Canada Research Chair in Immunogenomics (2005) and has received a CIHR Senior Scientist Award (2000-2005), an Arthritis Society of Canada Research Scientist Award (1992-2001), an Ontario Ministry of Health Cancer Scientist Award (1986-1996) and the Canadian Life and Health Association Medical Scholarship (1986-1992).
Dr. Siminovitch provides scientific leadership and oversight ensuring that Inagene Diagnostics' genetic testing and recommendations are based on the highest level of stringency and reliability in the industry.
Gideon Soesman is co-founder of GreenSoil Investments, a group of venture capital funds that funds companies with transformative technologies that change how we use the world’s resources. Before co-founding GreenSoil, Gideon founded and managed GMS Capital, a boutique investment bank. At GMS Capital, Gideon worked with several companies on their global business development strategy, helped companies raise funds and managed several mergers and acquisitions for European, American and Israeli companies.
Before GMS Capital, Gideon was responsible for all global merger and acquisition activities for a major division of Royal Philips Electronics. While acting as Senior Director of Corporate Mergers & Acquisitions, Gideon managed deals valued at over $1.5B. At Philips, Gideon also served as Director of Corporate Strategy & Venturing, with overall responsibility for all deal flow management, due diligence, deal negotiations, and portfolio management in Israel.
Prior to joining Philips, Gideon held senior positions at Shaldor and Ergo, both leading strategic management consulting firms in Israel and served as a project manager at MATI, the Centre for Entrepreneurship Development. Gideon holds a B.A. in Economics from the Hebrew University, Jerusalem, and an M.A. in Business Administration from the Boston University / Ben-Gurion University of the Negev. He immigrated to Israel from the Netherlands in 1990.
Director and Chief Executive Officer
Nancy White took on Inagene’s commercial leadership as its Vice President, Marketing and Sales in January 2019. She is a strategic leader with a proven track record in sales, marketing, operations and strategy in the health care, technology and government sectors. Nancy has more than 20 years of commercial and operational experience in bringing oncology, specialty and primary care treatments to doctors and patients. Throughout her career she has mobilized and managed sales and marketing for more than 25 health care brands pre-launch, launch, and lifecycle management through to loss of exclusivity (LOE). She has won a number of marketing awards and held roles of increasing responsibility and scope. Nancy has held a number of senior executive level roles in the pharmaceutical industry and has worked at Novartis Pharmaceuticals, Novartis Oncology, Allergan and Eli Lilly; she has worked in Canada, the United States, and Latin America. She holds a Bachelor of Commerce.